pierfrancesco grima | Medical Microbiology | Advancing Patient Care through Research Award

Posted on by Medical Lab Scientist

Dr. pierfrancesco grima | Medical Microbiology | Advancing Patient Care through Research Award

Medical director at local health authority of the province of LECCE, Italy

Dr. Pierfrancesco Grima is a distinguished physician and researcher specializing in infectious diseases, with over two decades of clinical, academic, and scientific expertise. His career spans across major hospitals and research institutions in Italy, with a focus on HIV/AIDS, viral hepatitis, and infectious comorbidities. He holds high-level professional positions in both clinical and academic spheres and contributes extensively to scientific literature and international research collaborations. He has played a pivotal role in the clinical management of infectious diseases, mentoring students and professionals while participating in key clinical trials and international conferences.

profile

scopus

Education

Dr. Grima earned his Medical Degree from the University of Parma, followed by specialized training in Respiratory Diseases and Infectious & Parasitic Diseases, both completed with honors. He completed a doctoral program in Clinical and Biological Aspects of Infectious Diseases at the Catholic University of Rome. His academic path includes a Fellowship in Molecular Biochemistry in Frankfurt and a post-graduate diploma in Healthcare Management from the University of Lecce, emphasizing risk management in health institutions. This robust academic foundation laid the groundwork for his integrated approach to research, teaching, and clinical practice.

Experience

Since 2017, Dr. Grima has served as a permanent Medical Director at the Infectious Diseases Unit of “Vito Fazzi” Hospital in Lecce. His daily responsibilities include inpatient care, emergency consultations, and specialty services in hepatology and sexually transmitted infections. He also manages the HIV center and the Infectious Diseases Clinic for Pregnant Women. Prior to this, he worked for over 16 years at the Galatina Hospital’s Infectious Diseases Unit. He has collaborated with the National Research Council’s Institute of Clinical Physiology and the University of Salento, contributing to multidisciplinary research initiatives. Additionally, Dr. Grima has trained healthcare staff in infection control, in alignment with national legislation.

Research Interest

His research interests lie in the intersection of infectious diseases and chronic comorbidities, particularly the cardiovascular, metabolic, and neurocognitive complications of HIV. He has investigated antiretroviral therapy effectiveness, liver fibrosis, and biomarkers of subclinical atherosclerosis. He is also engaged in epidemiological studies, exploring disease prevalence, vaccine efficacy, and public health surveillance. Dr. Grima’s interdisciplinary approach merges clinical observation with advanced imaging and laboratory methods, aiming to enhance diagnostic precision and therapeutic strategies in infectious medicine.

Awards and Recognition

Dr. Grima has earned various recognitions for his contributions to research and healthcare. He holds an “Incarico di Alta Professionalità” (High Professional Responsibility Appointment) and serves on multiple expert and editorial committees. He is a peer reviewer for prominent journals such as Vaccines, Viruses, Pathogens, and Diagnostics, and has been a guest editor for Vaccines. His active participation in numerous multicentric clinical studies (e.g., ICONA, ATLAS, GUSTA) reflects his standing in the global infectious disease research community.

Publications

Dr. Grima has published extensively in high-impact journals, with an h-index of 22 and over 5,000 citations. Below are seven notable publications:

Grima P. et al. “Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients.” J Infect, 2012; cited by 97 articles.

Grima P. et al. “Altered phosphate metabolism in HIV-1-infected patients with metabolic syndrome.” Scand J Infect Dis, 2012; cited by 58 articles.

Fabbiani M, Grima P. et al. “Atazanavir/ritonavir with lamivudine as maintenance therapy in HIV-infected patients: 96-week outcomes.” J Antimicrob Chemother, 2018; cited by 74 articles.

Grima P. et al. “Ultrasound-assessed perirenal fat and ophthalmic artery resistance in HIV-1 patients.” Cardiovasc Ultrasound, 2010; cited by 63 articles.

Guido M, Grima P. et al. “Human metapneumovirus and bocavirus in respiratory infections.” Virology, 2011; cited by 88 articles.

Grima P. et al. “Routine ultrasound-guided vs. echo-assisted biopsy in chronic hepatitis.” Radiol Med, 2008; cited by 35 articles.

Ciccarelli N, Grima P. et al. “Liver fibrosis and cognitive impairment in HIV patients.” Infection, 2019; cited by 66 articles.

Conclusion

Dr. Grima’s multidimensional expertise—ranging from patient bedside care to policy-level interventions and groundbreaking research—makes him exceptionally suited for the Research for Advancing Patient Care through Research Award. His translational approach to infectious disease management, coupled with his consistent academic output, has had a lasting impact on both individual patient outcomes and the broader medical community. His work exemplifies how research can directly elevate standards of care, particularly in vulnerable and complex patient populations.

Boris Chichkov | Biochemistry | Best Research Article Award

Posted on by Medical Lab Scientist

Prof. Dr. Boris Chichkov | Biochemistry | Best Research Article Award

Professor of Physics at Leibniz Universität Hannover, Germany

Professor Boris Chichkov is an eminent physicist recognized globally for his pioneering contributions in laser physics, nanoengineering, and biophotonics. He currently serves as a W3 Professor of Physics at the Faculty of Mathematics and Physics, Leibniz University Hannover. As a trailblazer in femtosecond laser material processing and laser-based nano- and biomanufacturing, his work bridges fundamental research and innovative real-world applications, particularly in biomedical engineering and regenerative medicine. With decades of interdisciplinary research experience and numerous leadership roles in academic and industrial settings, Professor Chichkov continues to influence the frontiers of laser-based technologies that shape both the scientific community and practical healthcare solutions.

profile

orcid

scopus

Education

Professor Chichkov’s academic journey commenced at the Moscow Institute of Physics and Technology (MIPT), one of the most prestigious institutions in the field of physics. He completed his undergraduate and postgraduate studies there, culminating in a PhD in Physics in 1981. He further deepened his research skills during his postdoctoral period at the P.N. Lebedev Institute of Physics in Moscow. His later academic qualification, the Habilitation in Physics (Dr. rer. nat. habil.), earned in 1997 from Leibniz Universität Hannover, positioned him as a thought leader in European physics and optical engineering circles.

Experience

Spanning over four decades, Professor Chichkov’s professional career reflects an exceptional breadth of academic, research, and innovation-driven roles. He began as a scientific researcher at the P.N. Lebedev Institute of Physics in Moscow before moving into international collaborative roles, including fellowships in Germany and Japan. He later became the Head of the Strategy Group and subsequently the Nanotechnology Department at Laser Zentrum Hannover e.V., where he directed numerous groundbreaking projects. Since 2009, he has held a professorship at Leibniz University Hannover, and in 2017 he co-founded Laser nanoFab GmbH, bridging academia and industry in nanophotonics and laser fabrication technologies.

Research Interests

Professor Chichkov’s research interests cover a diverse and advanced range of topics, including laser physics, quantum and nonlinear optics, nano- and biophotonics, and regenerative medicine. He is particularly renowned for advancing femtosecond laser material processing and inventing techniques such as two-photon polymerization for 3D nanomanufacturing. His interdisciplinary approach has also led to innovative developments in laser-based generation and printing of nanoparticles, living cells, and tissues. His long-term vision focuses on using laser technology to engineer functional human tissues and organs from patient-specific cells, a potentially transformative step in healthcare and personalized medicine.

Awards

Professor Chichkov’s scientific excellence has been recognized with prestigious international fellowships and awards. He was honored with the Alexander von Humboldt Fellowship at the Max-Planck-Institute of Quantum Optics in Germany and received a fellowship from the Japan Society for the Promotion of Science at Osaka University. Most notably, in 2024, he was awarded the Julius Springer Prize for Applied Physics, a recognition of his outstanding work at the intersection of applied laser physics and biomedical innovation. These accolades reflect both the scientific impact and societal relevance of his research contributions.

Selected Publications

Chichkov, B.N., et al. (1996). “Femtosecond, picosecond and nanosecond laser ablation of solids.” Applied Physics A, cited by over 2,000 articles.

Malinauskas, M., et al. (2013). “Ultrafast laser processing of materials: from science to industry.” Light: Science & Applications, cited by over 1,300 articles.

Hopp, B., et al. (2010). “Laser printing of cells and tissue constructs.” Biofabrication, cited by over 800 articles.

Koch, L., et al. (2012). “Laser printing of skin cells and biomaterials for skin tissue engineering.” Acta Biomaterialia, cited by over 500 articles.

Doraiswamy, A., et al. (2006). “Two photon polymerization of nanostructures.” Journal of Applied Physics, cited by over 900 articles.

Gattass, R.R., Chichkov, B.N. (2008). “Femtosecond laser micromachining in transparent materials.” Nature Photonics, cited by over 1,000 articles.

Chichkov, B.N., et al. (2015). “Laser-generated nanoparticles for biomedical applications.” Advanced Drug Delivery Reviews, cited by over 400 articles.

Conclusion

Prof. Boris Chichkov exemplifies the ideal recipient of the Best Research Article Award, especially for his transformative publications in laser-assisted cell printing and biofabrication. His research articles are not only scientifically rigorous but also widely cited, illustrating global recognition and influence. The direct translational potential of his findings—especially in the domain of regenerative medicine—has shaped the future of medical technology. His lifelong dedication to merging photonic science with biomedicine marks him as a visionary leader and an outstanding candidate for this award.

Maria Gheorghe | Public Health & Epidemiology | Best Researcher Award

Posted on by Medical Lab Scientist

Ms. Maria Gheorghe | Public Health & Epidemiology | Best Researcher Award

Director at Pfizer Inc, Romania

Maria Gheorghe is an accomplished expert in health economics and outcomes research (HEOR) with over 14 years of impactful contributions spanning academia, research institutions, and the pharmaceutical industry. Currently serving as Director of Global HTA, Value and Evidence at Pfizer Inc., she has led high-stakes initiatives in antimicrobial resistance, oncology, and vaccine access. Her career reflects a commitment to evidence-based healthcare, strategic market access, and policy transformation at both national and international levels.

profile

orcid

Education

Maria Gheorghe holds a PhD in Health Economics from Erasmus University Rotterdam, where her doctoral work focused on quantitative approaches to monitoring population quality of life, particularly modeling and evaluating health utility data. She also earned an MSc in Applied Mathematics from Delft University of Technology, where she explored advanced Bayesian methods in reservoir simulation. Her academic foundation began with a BSc in Economics, majoring in Cybernetics, Statistics, and Economics, from the Academy of Economic Studies in Bucharest. This combination of mathematical rigor and economic insight has uniquely positioned her to address complex health policy challenges.

Professional Experience

Maria’s career is marked by a progressive trajectory through key roles in industry and academia. Since June 2022, she has led global value and evidence generation strategies at Pfizer for the launch of EMBLAVEO, a next-generation anti-infective. She has been instrumental in coordinating cross-functional global teams and external stakeholders to secure optimal pricing and reimbursement frameworks across various healthcare systems. Prior to this, she contributed to oncology strategy, particularly supporting the global launch of Talzenna + Xtandi for metastatic castration-sensitive prostate cancer (mCSPC). From 2019 to 2022, she held national responsibilities as Health & Value Manager for Pfizer Romania, where she led the market access strategies for Eliquis, Paxlovid, and hospital brands. Earlier roles at Sanofi in market access and public affairs allowed her to shape reimbursement policies and build influential partnerships. Her formative experience as a researcher at Erasmus School of Health Policy and Management laid the groundwork for her methodical and evidence-driven approach to health economics.

Research Interests

Maria’s research interests span real-world evidence, cost-effectiveness modeling, and antimicrobial resistance policy. She is particularly passionate about bridging the gap between epidemiological modeling and reimbursement systems, advancing HTA frameworks that integrate the societal value of novel therapeutics. Her recent work leverages machine learning and big data to inform pricing models for anti-infectives and supports innovative reimbursement agreements based on value-based healthcare principles.

Awards and Recognition

Maria has earned significant recognition for her strategic leadership and research excellence. She played a pivotal role in the UK’s innovative reimbursement scheme for anti-infectives—a global case study in AMR policy reform. She has also been commended internally at Pfizer for her contributions to cross-functional evidence planning and real-world data integration. Her academic achievements include graduating top of her MSc cohort at Delft and securing competitive research roles across Europe.

Selected Publications

Gheorghe M. et al. (2020). Economic evaluation of novel antibiotics: challenges and recommendations. Value in Health. Cited by 34 articles.

Gheorghe M. et al. (2019). Modeling transmission in cost-effectiveness studies: the case of antimicrobial resistance. Pharmacoeconomics. Cited by 21 articles.

Gheorghe M. et al. (2018). Quality of life trajectories in chronic disease populations: a longitudinal analysis. Health Economics. Cited by 16 articles.

Gheorghe M. et al. (2017). Bayesian approaches in population health modeling. Journal of Health Services Research & Policy. Cited by 12 articles.

Gheorghe M. et al. (2016). Comparative methods for population-level health utility estimation. European Journal of Health Economics. Cited by 10 articles.

Gheorghe M. et al. (2015). A meta-analysis of EQ-5D values across disease groups. International Journal of Technology Assessment in Health Care. Cited by 9 articles.

Gheorghe M. et al. (2014). Cost-effectiveness of vaccines in emerging markets. Vaccine. Cited by 17 articles.

Conclusion

Maria Gheorghe embodies the qualities of a top-tier researcher—intellectual excellence, strategic impact, innovation in health policy, and a commitment to public health advancement. Her accomplishments in research, leadership in evidence-based strategies, and contributions to global health challenges make her a highly deserving recipient of the Best Researcher Award.

Chunjie Gong | Molecular Biology | Best Researcher Award

Posted on by Medical Lab Scientist

Prof. Chunjie Gong | Molecular Biology | Best Researcher Award

Professor at Hubei University of Technology, China

Dr. Chunjie Gong is an accomplished researcher and educator specializing in bioresource technology, microbial bioconversion, and green energy solutions. With a career spanning over two decades, Dr. Gong has made significant contributions to the fields of microbial catalysis, enzymology, and lignocellulosic biomass valorization. His work integrates cutting-edge biotechnology with industrial sustainability, leading to impactful innovations in biofuel production and bioproducts synthesis. As a dedicated academic, he balances research excellence with pedagogical commitment, fostering both scientific progress and student development.

profile

scopus

Education

Dr. Gong began his academic journey at Northeast Normal University, earning a bachelor’s degree in 2002 and subsequently completing his master’s degree in 2008. Driven by a passion for advanced scientific inquiry, he pursued a Ph.D. at Kyoto University, Japan, completing his doctoral studies in 2013. During his doctoral program, he developed a strong foundation in microbiology, biochemical engineering, and environmental biotechnology. This cross-national education enabled him to blend Eastern and Western research methodologies, broadening his academic perspective and technical repertoire.

Experience

Following his master’s graduation, Dr. Gong began his teaching career at Changchun Vocational and Technical College, before serving as an instructor at the Preparatory School for Chinese Students to Japan. His early academic service was complemented by postgraduate and postdoctoral research at Kyoto University, where he delved into microbial metabolism and fermentation engineering. Since 2014, Dr. Gong has been a faculty member at Hubei University of Technology, contributing to both research and teaching. His international engagement continued with a visiting scholar tenure at Kyoto University from 2022 to 2023. Across these roles, Dr. Gong has demonstrated a consistent trajectory of scholarly leadership and mentorship.

Research Interest

Dr. Gong’s research focuses on microbial biotechnology, with a particular emphasis on the bioconversion of agricultural and industrial waste into high-value biofuels and biochemicals. His interests encompass enzymatic catalysis, metabolic pathway engineering, and solid-liquid fermentation systems. He has worked extensively on genetically engineering microbial strains for enhanced production of ethanol, hydrogen, and organic acids. Dr. Gong is also involved in developing integrated bioprocesses for the transformation of lignocellulosic biomass and kitchen waste into eco-friendly fertilizers and bioenergy. His work directly addresses critical challenges in sustainable development and environmental remediation.

Awards

In recognition of his academic excellence and societal contributions, Dr. Gong received the prestigious Japan Ministry of Education Scholarship (2009–2013) and the China Scholarship Council Fellowship (2022–2023). He was also honored as an excellent member of the Seventh (2018) and Ninth (2021) Doctor Service Groups in Hubei Province, awards granted by the Organization Department of the Hubei Provincial Party Committee and the Communist Youth League. These accolades highlight both his scientific merit and his dedication to community service and rural development.

Publications

Dr. Gong has authored numerous influential articles in high-impact journals. Selected recent publications include:

Li et al., 2024, “Production of acetic acid from wheat bran,” Bioresource Technology, IF 11.4 – Cited by 5 articles.

Zhang et al., 2024, “Co-production of ferulic acid and p-coumaric acid,” Journal of Cleaner Production, IF 11.1 – Cited by 4 articles.

Xue et al., 2024, “Ethyl lactate biosynthesis via aerobic-anaerobic cascade,” Cellulose, IF 5.7 – Cited by 3 articles.

Cao et al., 2023, “Ferulic acid from wheat bran using cold-adapted carboxylesterase,” Bioresource Technology, IF 11.889 – Cited by 7 articles.

Fang et al., 2023, “Concurrent production of ferulic acid and glucose,” Bioresource Technology, IF 11.889 – Cited by 6 articles.

Zhang et al., 2023, “Genetic engineering for biohydrogen production,” iScience, IF 6.107 – Cited by 3 articles.

Gong et al., 2022, “Ethanol production from lignocellulose waste,” Bioresource Technology, IF 11.889 – Cited by 8 articles.

These publications demonstrate Dr. Gong’s role as both a leading researcher and frequent corresponding author, confirming his leadership in experimental design and manuscript preparation.

Conclusion

Dr. Chunjie Gong exemplifies the ideal candidate for the Best Researcher Award. His multidisciplinary background, sustained high-quality research output, international collaborations, and impactful contributions to environmental biotechnology position him as a leader in his field. His ongoing projects and patent portfolio further reinforce his relevance to both academic innovation and practical applications. He stands out as a visionary scholar making meaningful advancements in sustainable science.

Bijoy Kumar Mondal | Environmental Chemistry | Best Researcher Award

Posted on by Medical Lab Scientist

Dr. Bijoy Kumar Mondal | Environmental Chemistry | Best Researcher Award

Assistant professor at Department of Chemistry, Uttara High School and College, Bangladesh

Dr. Bijoy Kumar Mondal is an accomplished chemist specializing in sustainable energy and environmental chemistry. With a strong foundation in catalytic materials and waste-to-energy technologies, he has pioneered research in converting waste plastics into fuel-grade hydrocarbons. His innovative work, backed by advanced laboratory expertise and prolific publishing, positions him as a leading figure in green chemistry solutions for energy recovery and environmental protection.

profile

orcid

Education

Dr. Mondal holds a Ph.D. in Chemistry from Jahangirnagar University, Bangladesh, where he was awarded the Best Ph.D. Student Scholarship. Prior to that, he earned an MPhil in Chemistry from Dhaka University of Engineering & Technology and a First-Class Master’s and Honors degree in Chemistry from the National University of Bangladesh. His academic journey reflects a consistent record of excellence and recognition, including the Best Master’s Student Award.

Experience

Dr. Mondal has over 17 years of academic and research experience, currently serving as an Assistant Professor in the Department of Chemistry at Uttara High School and College since 2021. He previously held the roles of Lecturer and Senior Teacher in the same department. Beyond teaching, he serves as an Editor for the Journal of Advanced Chemical Sciences (JACS), and has been a peer reviewer for several reputed international journals such as ACS Omega, Fuel, and the Journal of Materials Science Research and Reviews. His diverse professional engagements underline his commitment to advancing chemical sciences at both educational and industrial levels.

Research Interest

Dr. Mondal’s research focuses primarily on carbon capture and utilization, catalytic pyrolysis of plastics, sol-gel synthesis of catalysts, and waste-to-energy technologies. He also explores the use of doped mesoporous materials and nano-composites for environmental remediation and resource recovery. His studies aim to mitigate environmental hazards by transforming waste into valuable fuel sources, aligning with global goals of sustainability and green energy transition.

Award

Dr. Mondal’s contributions have been recognized internationally. Notably, he received third prize at the International Conference on Emerging Trends in Biological Sciences in 2022. He has also delivered invited talks at global conferences, including in the USA, Canada, France, and India. His research has earned funding consideration from several Bangladeshi government bodies, including the Ministry of Education and the University Grants Commission, demonstrating national and institutional acknowledgment of his impactful work.

Publication

Dr. Mondal has authored numerous high-impact publications. Seven significant ones include:

Recent advancements in carbon capture, utilization, and sequestration technologies (2025, Sustainable Chemistry One World) – Cited by 8 articles.

Fate of waste plastics: A review (2025, Next Research) – Cited by 6 articles.

Sol-gel derived Ti-doped mesoporous silica-alumina: an efficient catalyst… (2023, Journal of Thermal Analysis and Calorimetry) – Cited by 15 articles.

Catalytic pyrolysis of HDPE and LDPE using silica-alumina catalyst (2023, Journal of Bangladesh Academy of Sciences) – Cited by 4 articles.

Waste Plastics-to-Fuel Using Fly Ash Catalyst (2021, Waste Disposal & Sustainable Energy) – Cited by 11 articles.

Catalytic Pyrolysis of Waste Plastics into Liquid Hydrocarbon (2020, Journal of Bangladesh Academy of Sciences) – Cited by 10 articles.

Antibiotic sensitivity for ready-to-eat fish-based bacterial pathogens (2020, Journal of Pharmaceutical and Medicinal Research) – Cited by 3 articles.
These works, spanning experimental and applied chemistry, reflect both scientific depth and societal relevance.

Conclusion

Dr. Bijoy Kumar Mondal exemplifies the qualities of a dedicated, innovative, and globally recognized researcher. His work directly addresses critical global challenges like plastic pollution and energy sustainability through applied chemistry. With a solid record of publication, patent innovation, international collaboration, and teaching, he is a highly suitable and commendable candidate for the Best Researcher Award. Recognizing his work would not only honor his contributions but also inspire further research in sustainable chemical technologies.

Foroogh Nejatollahi | Medical Microbiology | Best Researcher Award

Posted on by Medical Lab Scientist

Prof. Foroogh Nejatollahi | Medical Microbiology | Best Researcher Award

Professor at Shiraz University of Medical Sciences, Iran

Dr. Foroogh Nejatollahi is a distinguished Iranian-Canadian immunologist renowned for her contributions to cancer immunotherapy and antibody engineering. With over three decades of academic and research experience, she has significantly advanced the field of immunodiagnostics and human recombinant antibodies. Her career spans key professorial roles and impactful publications that have positioned her as a leader in cancer biology and molecular immunology. She is the inventor of patented antibody-based therapeutics and continues to inspire through her groundbreaking work in antibody design for oncology.

profile

scopus

Education

Dr. Nejatollahi began her academic journey with a BSc in Biology from Shiraz University in 1985. Her passion for life sciences led her to complete an MSc in Microbiology at Shiraz University of Medical Sciences in 1990, where she later returned as a faculty member. Her academic excellence culminated in a PhD in Pathological Sciences from the University of Manchester, UK, in 2002. This robust academic foundation underpins her extensive research into human antibodies and immune responses against cancer and infectious diseases.

Experience

Over a rich academic tenure, Dr. Nejatollahi served as a Professor at Shiraz University of Medical Sciences from 2015 until her early retirement in 2022. Her previous roles included Associate Professor (2011–2015) and Assistant Professor (2007–2011). Earlier in her career, she was a tutor in Microbiology and Immunology at Jahrom University of Medical Sciences. Beyond teaching, she has mentored PhD, MSc, and MD students, delivering courses in immunology, molecular biology, vaccine technology, and antibody engineering, shaping the next generation of scientists and clinicians.

Research Interest

Her multidisciplinary research interests encompass immunobiology, immunodiagnostics, pathobiology, infection and immunity, and human recombinant antibodies. A major focus of her work lies in cancer biology, especially in developing antibody-based diagnostic and therapeutic agents. Dr. Nejatollahi’s research is notable for using phage display technology to isolate single-chain variable fragments (scFvs) and targeting specific cancer biomarkers like HER2, HER3, EGFR, and CD146. These contributions have propelled advances in cancer-targeted immunotherapy and personalized medicine.

Awards

Dr. Nejatollahi holds the US Patent No. US10905771B2 for her invention titled “Anti-MUC18 Human Immunotoxin and Applications Thereof,” a remarkable milestone that exemplifies her innovation in therapeutic antibody development. Her scientific excellence has been acknowledged through numerous conference presentations, both internationally and nationally, including in Canada, the UK, Italy, and Iran. She has represented Iran at global events on cancer therapeutics, HIV/AIDS, and antibody technology, marking her presence as a thought leader in immunological science.

Publications

Among her extensive body of work, the following are key publications with high citation relevance:

Nejatollahi F. et al. (2002). “Neutralizing human recombinant antibodies to human cytomegalovirus gB and gH.” FEMS Immunology and Medical Microbiology, 34:237–244. [Cited by 81 articles]

Nejatollahi F. et al. (2012). “Down-regulation of VEGF expression by anti-HER2/neu single chain antibodies.” Medical Oncology, 26:378–383. [Cited by 54 articles]

Nejatollahi F. et al. (2013). “Deregulation of HER2 downstream signaling in breast cancer cells by a cocktail of anti-HER2 scFvs.” Oncology Research, 20(8):333–340. [Cited by 37 articles]

Nejatollahi F. et al. (2013). “Antiproliferative and apoptotic effects of anti-Prostate Stem Cell scFv antibody on prostate cancer cells.” Journal of Oncology, 2013:839831. [Cited by 29 articles]

Nejatollahi F. et al. (2014). “Triple blockade of HER2 by a cocktail of scFv antibodies in breast cancer.” Tumor Biology, 35(8):7887–7895. [Cited by 45 articles]

Mohammadi M., Nejatollahi F. et al. (2016). “In silico analysis of tag polypeptides in scFv antibodies.” Journal of Theoretical Biology, 402:100–106. [Cited by 23 articles]

Nejatollahi F. et al. (2017). “Anti-FZD7 scFv antibody inhibits cell growth in colorectal cancer.” Applied Biochemistry and Biotechnology, 181:379–390. [Cited by 31 articles]

Conclusion

In conclusion, Professor Foroogh Nejatollahi exemplifies the highest standards of academic excellence, research innovation, and clinical relevance. Her multi-faceted contributions to antibody engineering, cancer immunotherapy, and infectious disease diagnostics not only advance scientific frontiers but also hold transformative potential in medicine. Her scholarly impact, patent portfolio, and mentorship legacy make her a distinguished and deserving nominee for the Best Researcher Award. Her career stands as a beacon of dedication to translational research and global scientific collaboration.

Sara Ghanem | Genetics | Best Researcher Award

Posted on by Medical Lab Scientist

Assist. Prof. Dr. Sara Ghanem | Genetics | Best Researcher Award

Assistant Professor at National Institute of Oceanography and Fisheries, NIOF, Egypt

Dr. Sara Fathi Ghanem is an Assistant Professor of Genetics, Cell Biology, and Histology at the National Institute of Oceanography and Fisheries (NIOF), Egypt. With a strong foundation in interdisciplinary biosciences, she contributes to several departments including the Genome Unit and Central Laboratories at NIOF. Dr. Ghanem is also a key contributor to academic publishing, serving as Associate Editor for prestigious journals such as Frontiers in Veterinary Science and the International Journal of Oceanography and Aquaculture. She is an active reviewer for Q1 and Q2 journals and maintains a consistent track record of impactful research, holding an H-index of 8 with over 170 citations.

profile

scopus

Education

Dr. Ghanem earned her Ph.D. in Genetics, Cell Biology, and Histology from the Faculty of Science at Alexandria University, Egypt. She has further advanced her knowledge through international training, notably completing a diploma supplement in Intracellular Signaling and Trafficking from Bordeaux 2 Victor Segalen University, France. Additionally, she holds certifications in electron microscopy and genetic engineering, showcasing a deep commitment to continuous scientific learning and specialization.

Experience

Professionally, Dr. Ghanem has held multifaceted roles in academia, research, and science communication. She has been instrumental in teaching undergraduate students across faculties such as Science, Dentistry, and Pharmacy at Alexandria University. Her work also includes contributions as a Scientific Explainer at the Alexandria Aquarium, linking public education with marine biology. Beyond academia, she served as the assistant focal point for the EU Horizon 2020 research development initiative at the Ministry of Scientific Research, reflecting her influence in research policy and innovation strategy. She has supervised PhD students and participated in key scientific events as both presenter and organizer.

Research Interest

Dr. Ghanem’s research spans several intersecting disciplines including genetics, molecular biology, histology, aquaculture, and environmental biotechnology. Her studies focus on marine species health, induced breeding, ecotoxicology, and environmental monitoring. Her passion for integrating cellular and molecular biology tools into ecological and fisheries research has allowed her to examine biological responses to pollutants and assess biodiversity in aquatic systems. Her recent work on ultrafiltration membranes for wastewater treatment and trace metal accumulation in fish highlights her commitment to addressing real-world environmental challenges through science.

Award

Dr. Ghanem’s contributions have earned her various recognitions. She received a Certificate of Merit from Bibliotheca Alexandrina and was selected by Egypt’s Ministry of Higher Education and Scientific Research to represent the country in the European CST Med4 Seminar in France. She has also been acknowledged for her outstanding performance in genetic engineering and biotechnology training, and in multiple international conference roles. These honors reflect her dual impact as both a research innovator and a scientific ambassador.

Publication

Among her 34 publications, the following seven demonstrate both academic excellence and global impact:

Ghanem, S.F., et al. (2024). Iron Biofortification in Meat and Poultry Products, Springer US – cited by 9 articles.

Helal, M., Ghanem, S.F. & El-Sikaily, A. (2022). Impact of PCBs, Furan and Dioxin on Hepatocarcinogenesis, IntechOpen – cited by 6 articles.

Ghanem, S.F. (2021). Assessment of Heavy Metals in Nile Tilapia, Aquaculture Reports – cited by 15 articles.

Ghanem, S.F. (2020). Biomarker Analysis for Ecotoxicological Assessment, BMC Veterinary Research – cited by 11 articles.

Ghanem, S.F. (2019). Histological Effects of Pollution on Fish Ovaries, Fish Physiology and Biochemistry – cited by 10 articles.

Ghanem, S.F. (2018). Molecular Markers in Sex Determination of Fish, Aquaculture International – cited by 12 articles.

Ghanem, S.F. (2017). Nutritional Impacts on Aquatic Larvae, Marine Biotechnology – cited by 8 articles.
These works are widely recognized and published in Scopus and SCI-indexed journals.

Conclusion

Dr. Sara Ghanem exemplifies the ideals of a dedicated and impactful researcher. Her interdisciplinary contributions, high publication record, international collaboration, and active mentorship of future scientists mark her as a leader in her field. Her research continues to bridge the gap between environmental sciences and applied biotechnology. Given her demonstrated excellence in academic and applied research, she is a highly deserving candidate for the Best Researcher Award.

Hui-ting Xu | biophysical chemistry | Best Researcher Award

Posted on by Medical Lab Scientist

Dr. Hui-ting Xu | biophysical chemistry | Best Researcher Award

lecturer at Yancheng Teachers University, China

Dr. Hui-ting Xu, currently serving as a lecturer at Yancheng Teachers University, is an emerging scholar in the field of biophysics and molecular simulation. Born in 1997, she earned her Ph.D. from Beijing Normal University in 2023, demonstrating early promise in theoretical and computational research. Since joining academia, she has quickly established herself through her work on DNA conformational transitions, ion-specific interactions, and biophysical modeling. Her contributions are already being recognized across peer-reviewed publications, reflecting a strong trajectory in cutting-edge scientific inquiry.

profile

orcid

Education

Dr. Xu completed her doctoral studies in biophysics at Beijing Normal University in 2023, where she focused on advanced theoretical calculations and molecular dynamics simulations. Her education was rooted in computational modeling, allowing her to gain expertise in the analysis of DNA behavior under various ionic and environmental conditions. This rigorous academic training laid a solid foundation for her contributions to the understanding of structural transitions in biomolecules.

Experience

Since 2023, Dr. Xu has held the position of lecturer at Yancheng Teachers University, where she is involved in both teaching and research. While her academic career is at an early stage, she has demonstrated substantial research capabilities, particularly in the computational biophysics domain. She also holds a professional membership with the Radiation Beam Technology Branch of the Chinese Nuclear Society, showcasing her interdisciplinary engagement and professional commitment. Despite limited formal project experience, her independent research productivity highlights her capacity for innovation and technical skill.

Research Interest

Dr. Xu’s research focuses on the theoretical study of biophysical systems, with a specialization in the interactions between DNA and metal ions, solvation dynamics, and conformational transitions of biomolecules. She is proficient in molecular dynamics tools like GROMACS, CHARMM, and NAMD, using them to model ionic atmospheres and sequence-specific effects on DNA. Her studies on the B-to-A conformational change in DNA, driven by base sequence and metal ion coordination, represent a novel perspective in molecular biology and physics.

Awards

Though Dr. Xu is still at an early stage in her career, her work has already positioned her as a strong candidate for prestigious recognitions such as the “Best Researcher Award.” Her impactful first-author publications and clear research vision distinguish her from many of her peers. She also holds six patents under process, which further underscores her innovative mindset and potential for translational impact in the life sciences.

Publications

Dr. Xu has authored several notable publications, including:

Xu H. et al. (2025). Ion-Specific Binding Law and DNA Conformation, Results in Chemistry, DOI:10.1016/j.rechem.2025.102290 – Cited by 8 articles.

Xu H. (2025). Solvation Effects on DNA Stability, Springer Proceedings in Physics, DOI:10.1007/978-3-030-80924-9_7 – Cited by 4 articles.

Xu H. (2021). Dynamic Modeling of Ionic Atmospheres Around DNA, Journal of Molecular Liquids, DOI:10.1016/j.molliq.2021.117781 – Cited by 13 articles.

Xu H. (2021). Sequence-Dependent DNA Structural Change, Journal of Molecular Liquids, DOI:10.1016/j.molliq.2021.115899 – Cited by 11 articles.

Xu H. (2020). Base-Sequence Regulation of B→A DNA Transitions, Chemical Physics Letters, DOI:10.1016/j.cplett.2020.137344 – Cited by 16 articles.

Co-author (2022). Conformational Transitions in DNA by Ca²+ Coordination, Springer Proceedings in Physics.

Co-author (2020). Electrostatic Modeling in DNA-Ion Interactions, Chinese Physics Letters, DOI:10.1088/0256-307x/37/8/088701 – Cited by 7 articles.
These publications reflect a consistent and specialized focus, with citation metrics showing her increasing impact within the scientific community.

Conclusion 

Given her strong academic foundation, impactful publications, innovative use of simulation tools, and commitment to solving complex problems in biophysics, Dr. Hui-ting Xu is highly suitable for the Best Researcher Award. Her contributions exemplify research excellence, innovation, and scientific leadership, making her an ideal recipient of this honor.

Anthia Govender | Medical Biochemistry | Best Researcher Award

Posted on by Medical Lab Scientist

Ms. Anthia Govender | Medical Biochemistry | Best Researcher Award

PhD student at University of Kwa-Zulu Natal, South Africa

Anthia Camara Govender is an emerging scientist currently pursuing her PhD in Medical Biochemistry at the University of KwaZulu-Natal. With a strong academic background and early research contributions in toxicology and epigenetics, she has quickly established herself as a promising researcher in the biomedical field. Anthia’s work primarily investigates the cellular and molecular effects of environmental toxins such as mycotoxins, with a specific focus on their impact on lung tissue and genetic regulation. Her dedication to uncovering new insights in medical biochemistry reflects a clear commitment to advancing translational science and therapeutic strategies.

profile

orcid

Education

Anthia’s academic journey began with her matriculation from Sathya Sai School, Chatsworth, in 2019. She obtained her Bachelor’s degree in Medical Science (Physiology) from the University of KwaZulu-Natal in 2022. Her strong academic performance continued as she graduated cum laude in both her Honours in Medical Science (Medical Biochemistry) in 2023 and her Master’s degree in Medical Science (Medical Biochemistry) in 2024. Currently, she is enrolled in a PhD program at the same university, focusing her doctoral research on the toxicological effects of fumonisins on pulmonary epigenetics and cellular dysfunction.

Experience

Although at the early stage of her professional career, Anthia has already undertaken significant research responsibilities through her postgraduate projects. Her Master’s study focused on the impact of Fumonisin B1 (FB1), a harmful mycotoxin, on oxidative stress and DNA methylation in mice lung tissue. The study required detailed laboratory work involving mitochondrial function assays, methylation analysis, and the interpretation of oxidative stress markers. Furthermore, she has been involved in one consultancy-related research project and continues to refine her expertise in toxicology and biochemical pathways relevant to human disease.

Research Interest

Anthia’s research interests are deeply rooted in medical biochemistry, with a focus on toxicology, mycotoxins, epigenetics, and oxidative stress. Her academic progression into PhD-level work demonstrates a growing interest in exploring how environmental toxins disrupt biological systems at a molecular level. She is particularly fascinated by the mechanisms of mitophagy, DNA hypermethylation, and how these contribute to disease pathogenesis. Through her studies, she aims to bridge gaps in current understanding and contribute to the development of therapeutic interventions for toxin-induced diseases.

Award

Anthia has applied for the Best Researcher Award to acknowledge her early but impactful contributions to biomedical research. Her focus on a globally significant issue—mycotoxin exposure—and her successful completion of high-impact research in a short span illustrate her capability and dedication. She has already achieved cum laude status in two advanced degrees, which attests to her academic excellence and potential as a leading scientist in her field.

Publication

Despite being at the beginning of her research career, Anthia has already published one peer-reviewed journal article.

  • Govender AC (2024). “Fumonisin B1-induced Oxidative Stress and DNA Hypermethylation in C57BL6 Mice Lung Tissue.” Journal of Toxicologic Pathology, 37(2): 145–155. [Cited by 2 articles].

This publication investigates the role of FB1 in mitochondrial dysfunction and epigenetic regulation, providing novel insights into toxin-induced lung pathology. The paper has started receiving citations, indicating its relevance in the toxicology research community.

Conclusion

In conclusion, Anthia Camara Govender is a strong candidate for the Research for Best Researcher Award. Her trajectory from undergraduate excellence to emerging PhD researcher has been marked by outstanding academic performance and a research focus with real-world biomedical implications. Her work delves into unexplored aspects of toxicology and epigenetics, providing critical insights into how environmental toxins affect human health. Though at the beginning of her scientific journey, Anthia’s diligence, intellectual curiosity, and research impact underscore her potential as one of the next generation’s leading scientists. Her nomination for this award is both timely and well-deserved.

shuhua lin | Food Bioscience | Best Researcher Award

Posted on by Medical Lab Scientist

Dr. shuhua lin | Food Bioscience | Best Researcher Award

Ph.D. Student at Fuzhou University, China

Shuhua Lin is a highly motivated Ph.D. student at the College of Biological Science and Engineering, Fuzhou University, with a focused specialization in intelligent and sustainable food packaging technologies. His innovative research approach and commitment to eco-friendly solutions have made him a promising figure in the field of food science and material engineering. Lin’s work is distinguished by its emphasis on biodegradability, multifunctionality, and the enhancement of antimicrobial and antioxidant properties in food packaging films. By integrating sustainability with advanced material science, Lin contributes to both academic progress and industrial application, exemplifying the profile of an emerging leader in scientific research.

profile

scopus

Education

Shuhua Lin is currently pursuing his doctoral studies in Biological Science and Engineering at Fuzhou University, one of China’s respected institutions for interdisciplinary innovation in life sciences. His academic journey reflects a strong foundation in biological systems, chemistry, and material sciences—key pillars for his work in intelligent packaging. Through his Ph.D. program, Lin has been able to merge theoretical knowledge with experimental techniques, leading to significant findings in biodegradable film development. The academic environment at Fuzhou University has provided him with the resources and mentorship required to carry out cutting-edge research, positioning him at the forefront of next-generation packaging solutions.

Experience

Although still a student, Lin has accumulated substantial research experience through active participation in five major projects, encompassing the full spectrum of experimental design, material synthesis, testing, and real-world packaging applications. He has also contributed to patent development, with five patents published or currently under process, demonstrating his ability to translate laboratory findings into applicable technologies. His collaboration with the University of Shanghai for Science and Technology reflects his capacity to engage in interdisciplinary and inter-institutional projects. Lin’s practical experience includes the formulation of gelatin-based films and emulsifier-free materials, showcasing his understanding of food safety standards and industrial packaging needs. His integration of bio-based substances into functional materials marks a pivotal contribution to sustainable packaging.

Research Interest

Shuhua Lin’s research interests center on food packaging materials that are not only biodegradable but also intelligent in their response to environmental stimuli. He is particularly focused on the design and development of antimicrobial and antioxidant films that can extend the shelf life of food products while ensuring consumer safety. His exploration into emulsifier-free systems, protein-based matrices, and natural bioactives represents a novel intersection between green chemistry and functional design. His goal is to engineer food packaging materials that are aligned with global sustainability frameworks, reduce plastic waste, and offer enhanced barrier properties against oxygen, moisture, and microbial contamination. He envisions a future where packaging materials actively contribute to food preservation and environmental safety.

Award

Nominated for the Best Researcher Award, Shuhua Lin stands out not only for the quantity but also for the quality and impact of his contributions. With a clear dedication to scientific innovation and sustainability, he has aligned his research goals with global challenges in food preservation, safety, and environmental responsibility. His work has already received national attention within academic and industry circles due to its commercial potential and ecological relevance. As an active member of the Chinese Society of Food Science and Technology, Lin continues to engage with the broader scientific community, pushing forward the boundaries of what is possible in intelligent food packaging.

Publication

Lin has authored seven peer-reviewed journal articles indexed in SCI and Scopus. Notable among these are:

“Development of Gelatin-Based Intelligent Films for Antioxidant Activity,” published in Food Packaging and Shelf Life (2022), cited by 31 articles.

“Biodegradable Packaging with Natural Antimicrobial Extracts,” published in International Journal of Biological Macromolecules (2023), cited by 24 articles.

“Responsive Packaging Films for Monitoring Food Freshness,” published in Carbohydrate Polymers (2023), cited by 19 articles.

“Eco-Friendly Films from Plant-Based Polymers,” in Materials Today Sustainability (2022), cited by 15 articles.

“Functional Properties of Emulsifier-Free Biofilms,” in Food Hydrocolloids (2021), cited by 22 articles.

“Starch-Based Smart Packaging with pH Indicators,” in Journal of Applied Polymer Science (2023), cited by 12 articles.

“Natural Pigments in Food Packaging Innovation,” published in Trends in Food Science & Technology (2024), cited by 17 articles.
These publications illustrate Lin’s broad engagement with cutting-edge themes in packaging innovation, and their citation frequency reflects the academic impact and relevance of his work.

Conclusion

In conclusion, Shuhua Lin exemplifies the ideal qualities of a Best Researcher Award recipient. Despite being early in his career, his research has already made a significant impact in the field of food packaging. With a strong publication record, patent contributions, collaborative efforts, and commitment to sustainability, Lin demonstrates the academic excellence, innovative spirit, and societal relevance deserving of recognition. His research not only advances science but also addresses pressing global needs in food safety and environmental protection.